The Drug Enforcement Administration (DEA) has rescheduled the cannabidiol (CBD) based drug Epidolex, but limited the rescheduling to exclude all CBD products. Epidiolex will be scheduled at Schedule 5, the lowest level of drug scheduling under the Controlled Substances Act (CSA). Epidiolex, … Read more about DEA Reschedules CBD-Based Epidiolex
In a blow to hemp-derived cannabidiol (CBD) product manufacturers who intend to use CBD as a food additive, the California Department of Public Health (CDPH), in conjunction with the California Food and Drug Branch (FDB), has released a clarification document titled: "FAQ - Industrial Hemp and … Read more about CBD in Food? California Says No Way, (San) Jose.
During a press conference at the US Hemp Roundtable in Frankfort, Kentucky, Senate Majority Leader Mitch McConnell announced a plan to introduce legislation next week that would protect and advance hemp production in the United States. The proposed Hemp Farming Act of 2018 would "finally legalize … Read more about Proposed Bill Would Legalize Hemp in US
As you may or may not know, the majority of the drugs in this country—both prescription and recreational—are regulated according to the “Schedule” they fall into. The scheduling system has five levels (I-V) and was established by the Controlled Substances Act. The restrictions and regulations … Read more about Schedule I?
If there is one thing that I can’t seem to get off my soapbox about, its industrial hemp and the impact it is going to have on a great many aspects of our everyday life. We’ve talked about the relative ease of its cultivation and how it could be grown on a truly gigantic scale (potentially hundreds … Read more about The Rise of CBD (and How it Can Benefit Hemp Growers)